A detailed history of Sit Investment Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Sit Investment Associates Inc holds 239,900 shares of AZN stock, worth $15.2 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
239,900
Previous 254,170 5.61%
Holding current value
$15.2 Million
Previous $19.8 Million 5.71%
% of portfolio
0.42%
Previous 0.46%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $1.09 Million - $1.25 Million
-14,270 Reduced 5.61%
239,900 $18.7 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $544,835 - $659,168
-8,155 Reduced 3.11%
254,170 $19.8 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $951,152 - $1.08 Million
-15,585 Reduced 5.61%
262,325 $17.8 Million
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $206,712 - $231,395
-3,340 Reduced 1.19%
277,910 $18.7 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $752,843 - $832,365
11,609 Added 4.31%
281,250 $19 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $12,863 - $13,949
-184 Reduced 0.07%
269,641 $19.3 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $549,657 - $623,206
8,704 Added 3.33%
269,825 $18.7 Million
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $805,560 - $1.05 Million
-14,860 Reduced 5.38%
261,121 $17.7 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $660,629 - $1.69 Million
12,460 Added 4.73%
275,981 $15.1 Million
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $1.4 Million - $1.68 Million
-23,675 Reduced 8.24%
263,521 $17.4 Million
Q1 2022

May 12, 2022

SELL
$55.72 - $67.12 $31,203 - $37,587
-560 Reduced 0.19%
287,196 $19.1 Million
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $544,521 - $643,406
-10,080 Reduced 3.38%
287,756 $16.8 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $2.03 Million - $2.23 Million
36,610 Added 14.01%
297,836 $17.9 Million
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $589,513 - $732,691
-12,175 Reduced 4.45%
261,226 $15.6 Million
Q1 2021

May 13, 2021

BUY
$47.16 - $54.44 $757,625 - $874,578
16,065 Added 6.24%
273,401 $13.6 Million
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $333,380 - $398,655
6,871 Added 2.74%
257,336 $12.9 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $1.51 Million - $1.74 Million
-28,475 Reduced 10.21%
250,465 $13.7 Million
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $1.84 Million - $2.12 Million
34,675 Added 14.2%
278,940 $12.4 Million
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $1.79 Million - $2.3 Million
-41,600 Reduced 14.55%
244,265 $12.9 Million
Q1 2020

May 13, 2020

BUY
$37.79 - $51.33 $77,469 - $105,226
2,050 Added 0.72%
285,865 $12.8 Million
Q4 2019

Feb 13, 2020

BUY
$42.46 - $50.46 $206,992 - $245,992
4,875 Added 1.75%
283,815 $14.2 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $2.58 Million - $2.92 Million
64,200 Added 29.9%
278,940 $12.4 Million
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $7.3 Million - $8.17 Million
195,940 Added 1042.23%
214,740 $8.86 Million
Q1 2019

May 14, 2019

BUY
$35.49 - $43.02 $507,507 - $615,186
14,300 Added 317.78%
18,800 $760,000
Q4 2018

Jan 14, 2019

BUY
$36.86 - $41.49 $165,870 - $186,705
4,500 New
4,500 $171,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.